| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/06/2010 | EP2139325A2 Anti-angiogenic agents and methods of use |
| 01/06/2010 | EP2079711B1 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 01/06/2010 | EP1635835B1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 01/06/2010 | EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases |
| 01/06/2010 | CN101622234A Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 01/06/2010 | CN101619043A Quinazoline derivant and medical application thereof |
| 01/06/2010 | CN101619042A Method for synthesizing aromatic pyrimidine-4(3H)-ketone compounds |
| 01/06/2010 | CN100577650C Catalyst for dissymmetric catalysis reaction and chiral ligand therein |
| 01/06/2010 | CN100577649C Electroluminescent device |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642303 Thermoplastic articles for packaging UV sensitive materials, processes for the articles production and use and novel UV absorbers |
| 01/05/2010 | US7642272 Cannabinoid receptor ligands |
| 01/05/2010 | US7642249 Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonist |
| 01/05/2010 | US7642220 crop selectivity |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2184681C Process for preparing substituted n-ethylglycine derivatives |
| 12/31/2009 | US20090326225 Novel Process for the Preparation of Hexacyclic Compounds |
| 12/31/2009 | US20090326081 Polymer material comprising cross-linked spherical particles, a method for producing the material and uses thereof |
| 12/31/2009 | US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 12/31/2009 | US20090325987 Quinazolinedione derivatives as trpa1 modulators |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/31/2009 | US20090324495 Compounds and methods for enzyme-mediated tumor imaging and therapy |
| 12/31/2009 | DE102008030091A1 Uracilderivate und deren Verwendung Uracil derivatives, and their use |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158404A1 Methods of preparing quinazolinone derivatives |
| 12/30/2009 | WO2009157014A2 A process for preparing hmg-coa reductase inhibitors and intermediates |
| 12/30/2009 | WO2009156182A2 Uracil derivatives and use thereof |
| 12/30/2009 | WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/30/2009 | WO2009134658A3 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
| 12/30/2009 | WO2009114459A3 Anti-neoplastic combination therapy comprising co-disruption pathway and mre11/rad50/nbs1 complex and compositon thereof |
| 12/30/2009 | WO2009102997A3 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
| 12/30/2009 | WO2009099553A3 Use of kinase inhibitor in treatment of atherosclerosis |
| 12/30/2009 | EP2138482A1 Bicyclic heterocyclic compound |
| 12/30/2009 | EP2137166A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases |
| 12/30/2009 | EP2137165A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2137164A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2137163A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2136635A1 Chemical compounds |
| 12/30/2009 | EP1732902B1 Nucleoside derivatives and therapeutic use thereof |
| 12/30/2009 | EP1608632B1 Quinazolines useful as modulators of ion channels |
| 12/30/2009 | CN101613323A Method for synthesizing medicinal sulfadiazine silver |
| 12/30/2009 | CN101613322A Synthesis and herbicidal activities against grass weeds of pyridine-containing chiral quinoxalinyloxy phenoxy propionate derivatives |
| 12/30/2009 | CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 12/30/2009 | CA2727455A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | CA2711103A1 Methods of preparing quinazolinone derivatives |
| 12/29/2009 | USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases |
| 12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 12/29/2009 | US7638522 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
| 12/29/2009 | US7638520 Pyrimidine compounds |
| 12/29/2009 | US7638515 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 12/29/2009 | US7638514 Agriculture |
| 12/29/2009 | US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2410311C Barbituric acid analogs as therapeutic agents |
| 12/29/2009 | CA2408914C Novel triazolo pyrimidine compounds |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them |
| 12/29/2009 | CA2300243C Process for preparing n-[5-(diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-n-methylmethanesulphonamide |
| 12/24/2009 | US20090318688 Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of derivatives |
| 12/24/2009 | US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds |
| 12/24/2009 | US20090318483 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist; |
| 12/24/2009 | US20090318481 Potentiators Of Glutamate Receptors |
| 12/24/2009 | US20090318478 Quinazoline derivatives |
| 12/24/2009 | US20090318477 Chemical compounds |
| 12/24/2009 | US20090318444 Tetrahydro- and dihydroquinazolinones |
| 12/24/2009 | US20090318407 Inhibitors of protein kinases |
| 12/24/2009 | US20090318373 Receptor-type kinase modulators and methods of use |
| 12/23/2009 | WO2009155001A2 Wnt protein signalling inhibitors |
| 12/23/2009 | WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 12/23/2009 | WO2009133379A3 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 12/23/2009 | WO2009097682A8 Anti-influenza compounds |
| 12/23/2009 | WO2009092702A3 ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production employing a 2-deoxyribose-5-phosphate aldolase |
| 12/23/2009 | WO2008155140A8 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/23/2009 | WO2008142550A8 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 12/23/2009 | EP2134696A2 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| 12/23/2009 | EP2134695A1 Inhibitors of the hedgehog pathway |
| 12/23/2009 | EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety |
| 12/23/2009 | EP1506169B1 Method for the production of sulphonic acid diamides |
| 12/23/2009 | CN101610893A Dithiolene metal complex colorless IR absorbers |
| 12/23/2009 | CN101607943A Quinazolone anti-coccidia compound containing 1-methoxy-naphthyl |
| 12/23/2009 | CN100572364C HIV replication inhibiting pyrimidines and triazines |
| 12/23/2009 | CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 12/22/2009 | US7635701 Pyrimidine derivatives and their use as CB2 modulators |
| 12/22/2009 | US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease |
| 12/22/2009 | CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 12/17/2009 | US20090312554 Novel Process for the Preparation of Hexacyclic Compounds |
| 12/17/2009 | US20090312547 Process for preparation of rosuvastatin calcium field of the invention |
| 12/17/2009 | US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof |
| 12/17/2009 | US20090312351 Processes for the Preparation of Alfuzosin |
| 12/17/2009 | US20090312328 Sulfonamide compound or salt thereof |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |